Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"ClinicalTrials.gov"
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Neuroblastoma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Neuroblastoma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Neuroblastoma%22&type=Subject
PubPharm (136)
1
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children : A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). : Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma : Phase 2 Trial of Metronomic Treatment in Children and Adolescents With Recurrent or Progressive Neuroblastoma (NB)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Ensartinib in Patients With Tumors Harboring ALK or ROS1 Genomic Alterations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) : A Randomized, Placebo-Controlled Pilot Study of Genistein Supplementation in Pediatric Cancer Patients Receiving Myelosuppressive Chemotherapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma : Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy in Patients With High-Risk Neuroblastoma Receiving Tandem Transplants
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma : Phase II Single Arm Study to Assess Dinutuximab (Ch 14.18) Combined With the Cytokines Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) and IL-2 in Patients With High-risk Neuroblastoma Not Eligible to Other Immunotherapy Trials
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Filter aufheben
Thema: Phase: Phase 2
Medienart
136
Aufsätze
136
E-Artikel
136
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
136
610
136
Neuroblastoma
Phase: Phase 2
136
Study Type: Interventional
43
Recruitment Status: Completed
37
Neoplasms
37
Rhabdomyosarcoma
36
Sarcoma, Ewing
35
Sarcoma
34
Osteosarcoma
32
Recruitment Status: Active, not recruiting
31
Lymphoma
31
Medulloblastoma
31
Wilms Tumor
30
Neuroectodermal Tumors
30
Neuroectodermal Tumors, Primitive
29
Recurrence
28
Lymphoma, Non-Hodgkin
28
Neuroectodermal Tumors, Primitive, Peripheral
27
Hepatoblastoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
89
2020-
46
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
136
Englisch
Haven't found what you're looking for?
Wird geladen...